Samsung Biologics-2022 earnings
Samsung Biologics 2022 net income up 102.8 pct to 798.1 bln won
SEOUL, Jan. 27 (Yonhap) -- Samsung Biologics Co. on Friday reported its 2022 net income of 798.1 billion won (US$648.1 million), up 102.8 percent from a year earlier.
The company said in a regulatory filing that operating profit for the year rose 83.1 percent on-year to 983.6 billion won. Annual revenue increased 91.4 percent to 3 trillion won.
(END)
(C) Yonhap News Agency. All Rights Reserved
